Skip to main content
All lobbying filings

WASHINGTON ADVOCACY GROUP

WASHINGTON ADVOCACY GROUP filed a Q3 report for AMGEN INC. on October 14, 2025, reporting $15,000 in lobbying income.

Lobbying for AMGEN INC. · Biotechnology

All filings by WASHINGTON ADVOCACY GROUP · Everything AMGEN INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 14, 2025
Income
$15,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem